Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices | Zendy

Véronique Erard | Zendy; Katherine A. Guthrie | Zendy; Sachiko Seo | Zendy; Jeremy Smith | Zendy; MeeiLi Huang | Zendy; Jason W. Chien | Zendy; Mary E.D. Flowers | Zendy; Lawrence Corey | Zendy; Michael Boeckh | Zendy

Open Access

Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices

Author(s) -

Véronique Erard,

Katherine A. Guthrie,

Sachiko Seo,

Jeremy Smith,

MeeiLi Huang,

Jason W. Chien,

Mary E.D. Flowers,

Lawrence Corey,

Michael Boeckh

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ215

Subject(s) - medicine , hematopoietic cell , transplantation , pneumonia , cytomegalovirus , hematopoietic stem cell transplantation , cytomegalovirus infections , intensive care medicine , immunology , haematopoiesis , human cytomegalovirus , viral disease , virus , herpesviridae , stem cell , genetics , biology

Despite major advances in the prevention of cytomegalovirus (CMV) disease, the treatment of CMV pneumonia in recipients of hematopoietic cell transplant remains a significant challenge.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research